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Purpose: To present an overview of animal models of retinal artery occlusion (RAO).
Methods: Through a systematic literature search in PubMed and Embase, papers
describing methods of inducing RAO in animal models were included. The identified
methodologic approaches were presented in a narrative synthesis and compared with
RAO in humans.
Results: In total, 83 papers reporting on 88 experiments were included. Six different
species were used with rodents and monkeys being the most common, and a
minority were performed using cats, dogs, rabbits, or pigs. The anatomy of pigs and
monkeys resemble that of humans most closely. The two most frequently used
methods were laser-induced occlusion or ligation of the arteries. Other methods
included raised intraocular pressure, arterial clamping, administration of vasocon-
stricting agents, the use of an occluder, embolization, and endovascular approaches
to induce occlusion. In general, occlusions lasted for only 30 to 90 minutes, often
followed by reperfusion.
Conclusions: Although a broad range of methods have previously been used, they all
have limitations. Preferably, the methods should imitate the human disease as closely
as possible and avoid damaging other structures. Therefore, monkeys followed by
pigs are to be preferred and ligation or clamping may be a suitable model in larger
animals as there is a potential to isolate and occlude the retinal artery only. Being less
invasive, laser-induced occlusion is another suitable approach.
Translational Relevance: This review aims at assisting researchers in deciding on the
most ideal experimental setting, and thereby increase the translational value to
human disease.
Introduction
Retinal artery occlusion (RAO) can cause severe
and irreversible vision loss. RAO is divided into
branch retinal artery occlusion (BRAO) and central
retinal artery occlusion (CRAO) based on the site of
arterial occlusion. It is most often caused by an
embolism resulting in infarction of the inner retina
and may be regarded as the ocular analogue to
cerebral stroke.1,2 Various treatment strategies for the
acute management have been explored, such as ocular
massage and thrombolysis; however, no treatment has
yet been shown to be effective.3 In order to develop
treatment that can limit the extent and severity of
ischemic injury, a deeper understanding of the
pathophysiology and biochemical processes is needed.
Experimental animal models of RAO have the
potential to broaden our knowledge of the disease
in general and lead to the development of new
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treatments in particular. Also, retinal tissue is
accessible in animal models allowing for advanced
analyses directly at the retinal level where RAO is
located.
Numerous experimental animal studies of RAO
have previously been performed using a variety of
different methodologic approaches with varying
similarities to human conditions. However, the use
of different models for inducing illness and disparate
animal species, among other factors, makes it difficult
to compare and extrapolate findings with humans.4
Indeed, criticism has been raised against several of the
previously employed methods.5,6 Improvement and
standardizations of the scientific method followed by
systematic review may increase the translational value
to human disease.4
Therefore, the aim of the present paper was to
present a comprehensive overview of previously
applied methodologic approaches that can be used
for conducting animal models of RAO in order to
assist future researchers in deciding on the most ideal
experimental setting.
Methods
For this review, a systematic literature search was
conducted in PubMed and Embase (Supplementary
Tables S1 and S2). Prior to the search, a protocol was
written. Studies were included if their experimental
method induced occlusion of the retinal artery,
regardless if their primary aim was to set up a model
for RAO or not. The retrieved studies were examined
to exclude overlapping or duplicated data. Experi-
mental models of occlusion of vessels more proximal
than the ophthalmic artery were excluded, as these
more closely resembled manifestations of other
diseases, such as ocular ischemic syndrome.
For each included study, the species used in the
study was noted, method of inducing the occlusion,
time of occlusion, and reperfusion if applicable, as
well as validation of the occlusion. Results were
presented using narrative synthesis, including discus-
sion of the advantages and challenges in the various
methodologic approaches.
Results
In all, 268 studies were identified after duplicates
were removed, and a total of 83 studies were included
(Fig. 1). Five of the included studies had used more
than one method of inducing RAO and therefore each
method was included separately in the synthesis.
Hence, a total of 88 reports were included.
The majority of the included studies most closely
resembled CRAO. However, 23 induced one or more
BRAO. Of these, 13 used lasers,7–18 five used
embolization,19–23 one used heat coagulation by the
use of a probe,24 and four used a probe or an
occluder.24–27
Species
A number of different species have been used
(Table 1). Rodents are the most commonly used
species in the experimental animal models, the second
most frequently used species being monkeys. A
smaller number of experimental setups included cats,
dogs, rabbits, or pigs. Especially, dogs, cats, and pigs
were used in studies using methods requiring larger
animals (occluder/probe, endovascular techniques, or
embolization).
The resemblance to human anatomy varies widely
among the species. In monkeys, the vascular archi-
tecture is very similar to humans.89 Furthermore,
monkeys have a macula as in humans, as opposed to
the other species included. Overall, the structure of
the retinal vascular system of the pig is similar to that
of humans too.90,91 Diverging results exist regarding
the presence of a central retinal artery (CRA) in the
pig. Some authors report of a single retinal artery
giving rise to several branches,86 while others report
of no formation of a CRA.92 The findings suggest
that the retinal arteries may either arise from the
ciliary artery as several branches, or as a single
branch, which quickly divides. Once the nerve head is
reached, only branches are visualized, typically four.90
In contrast to humans and the other species used,
both cats and dogs have a tapetum lucidum, which is
a reflective layer improving vision in dim light.93,94 In
the cat, three major arteries and two to six smaller
arteries run from the optic disc to the periphery.95 In
the dog, there is no CRA. Instead, multiple vessels
pierce the sclera, branching off usually three or four
retinal arteries. As opposed to humans, the arteries
show tortuosity.89
The retinal vascular system of the rabbit eye is
distinctly different from the human eye and the other
species used in the identified studies as the rabbit
retina is merangiotic (presence of blood vessels in a
limited part of the retina leaving the rest of the retina
avascular).95,96 Furthermore, the retinal circulation of
the rabbit may play little role in maintaining retinal
function as monitored by the electroretinogram
(ERG), as suggested by Ciulla et al.38
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Method of Inducing RAO
Overall, RAO was induced by several methods,
including laser, vasoconstriction by injection of
chemical substances, increased intraocular pressure
(IOP), embolization, or arterial occlusion by using a
clamp or suture mainly, or by using an occluder
(Table 1 and Fig. 2).
Laser
Sixteen studies used laser photocoagulation (Table
2). It was most often performed using an argon laser
with wavelengths varying between 514 to 577 nm.
Often, a photosensitizing agent was used to increase
laser absorption and minimize the amount of laser
required to produce occlusion. Hence, nine studies
Table 1. Animal Species and Techniques Used to Produce Occlusion
Rodents,
n
Rabbits,
n
Cat,
n
Dog,
n
Pig,
n
Monkey,
n
Combination,
n
Total,
n References
Laser, n 14 4 0 0 0 4 1 23 7–18,28–37
Vasoconstriction, n 2 3 0 0 0 1 0 6 16,38–42
Raised IOP, n 9 1 0 0 0 1 0 11 43–53
Clamp, n 0 0 0 0 0 9 0 9 5,18,54–60
Ligation, n 20 1 0 0 0 3 0 24 38,61–83
Occluder, probe, n 0 0 5 0 0 0 1 6 24–27,84
Embolization, n 0 1 0 2 3 0 0 6 19–23,85
Endovascular technique, n 0 0 0 0 3 0 0 3 86–88
Total, n 45 10 5 2 6 18 2 88
Figure 1. Flow chart of study selection procedure.
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used rose bengal and seven studies used no photo-
sensitizer.
Six studies used photodynamic therapy or a
photodynamic therapy–like method.7–9,11,13,28 In
these studies, a photosensitizing agent was adminis-
tered intravenously or, in one study, intraperitoneal-
ly13 followed by application of laser or another light
source for a duration varying from 2 to 45 minutes.
One study used laser to induce targeted delivery of
a platelet-activating agent, in this case adenosine
diphosphate.12
If a CRAO was induced by laser, the laser beam
was oriented at the optic disc. If one or more BRAO
was aimed for, then the laser beam was targeted at
one or more arterioles, typically near the optic disc.
Vasoconstriction
Apart from one study using serotonin, vasocon-
striction was induced by administration of endothe-
lin-1, which is a potent vasoconstrictor produced by
vascular endothelial cells.39 Generally, endothelin-1
was either injected in the posterior vitreous body over
the optic disc, which causes constriction of all retinal
vessels, including both veins and arteries,16,38,39,40 or
it was injected in the subconjunctival space in the
posterior part of the eyeball causing constriction of
the CRA.41 It is not evident if this last method causes
constriction of other vessels too.
Serotonin was used in one study to test the
hypothesis that serotonin may cause vasospasm in
atherosclerotic monkeys. In total, nine monkey eyes
were used, and in four of these an occlusion of the
CRA was evident, an additional two showed slight
filling delay.42
Raised IOP
Most frequently, occlusion or ischemia was pro-
duced by cannulating the anterior chamber with a
tube connected to an elevated reservoir containing
saline. The IOP is then elevated to typically 120 mm
Hg (range, 90–160 mm Hg). In one study, the IOP
was increased by inserting and inflating an arterial
embolectomy catheter balloon retrobulbarly to simu-
late orbital hemorrhage.43 This resulted in occlusion
of the CRA in two of 16 monkeys.
Clamp
This method consisted of performing a lateral
orbitotomy followed by clamping of the CRA at its
site of entry into the optic nerve dural sheath. It was
performed on monkeys in all nine studies using this
method.
Ligation
For this procedure, one study used a clip, the rest
used a ligature. For the large majority, the procedure
of ligating the CRA in rodents included ligation of the
optic nerve and other vessels (posterior ciliary artery).
However, two studies using rodents reported applying
ligature solely on the CRA,61,62 only one of them with
a detailed description on how it was done.62 The optic
nerve was exposed by blunt dissection after a lateral
conjunctival dissection and removal of the lateral
rectus muscle. The CRA was exposed by longitudi-
nally opening the dural sheath surrounding the optic
nerve using fine scissors. The suture on the CRA was
positioned after the trifurcature of the ophthalmic
artery into the CRA and two posterior ciliary
arteries.62
All three studies on monkeys placed a ligature on
the CRA only.
Occluder/Probe
In studies using an occluder or a probe, the probe
or occluder was either produced from a steel needle or
from a glass probe tipped with a glass ball. For heat
coagulation, the probe was made by sealing tungsten
wire into a glass capillary tube with epoxy.
Two studies used a probe and in an identical
fashion. A puncture was made through the superior
lateral portion of the pars plana through which the
blocker probe was inserted. BRAO was then pro-
duced by pressing the probe on a branch artery. By
Figure 2. Methods used to induce RAO in the included studies.
4 TVST j 2019 j Vol. 8 j No. 4 j Article 23
Vestergaard et al.
Downloaded from tvst.arvojournals.org on 08/30/2019
pressing the probe on the optic nerve, it occluded the
entire retinal circulation.25,84
Three studies used an occluder and followed the
same procedure. That is, to produce a BRAO the ball
was pressed onto an artery emerging from the optic
disc.24,26,27
In one study, including two cats, the probe was
used to perform heat coagulation.24 The success of
occlusion was evaluated by inspecting the occluded
vessel by direct ophthalmoscopy.
Embolization
Studies that applied embolization-based methods
were carried out by injecting various substances in
either the carotid artery22,23,85 or the maxillary
artery.19–21
In three related studies, BRAO was produced in 6
of 27, 12 of 26, and 8 of 33 cases by injecting platelet
aggregates, fibrin clots, or leucocyte aggregates,
respectively.19–21 These experiments also produced
microinfarctions and hemorrhages.
Ciulla et al.22 used human atherosclerotic material,
the injection of which produced BRAO in five rabbits
and CRAO in four rabbits out of a total 12 animals.
In one study, the injection of air produced BRAO
in all animals if they were kept hypotensive.23
However, the occlusions lasted less than 10 minutes.
Long-acting corticosteroids were injected in one
Table 2. Parameters of Laser Photocoagulation for Each Study
Type of
Occlusion
Photo-
sensitizer Laser
Wavelength,
nm
Power,
mW
Spot
Size,
lm
Duration,
s
Number of
Applications,
n Reference
BRAO - NA NA NA NA NA NA 18
CRAO (and
CRVO)
- Argon NA 900 500 0.2–1 20 33
CRAO (and
CRVO)
- Argon NA 900 500 0.2–1 20 34
BRAO - Blue–green
argon laser
NA 100–200 50 0.1–0.2 Median 44 10
BRAO - Argon dye laser 577 80 50 0.1 10–20 13
CRAO Rose bengal,
20 mg/kg
Argon green
laser
514 100 50 0.3 NA 32
BRAO - Argon laser NA 150–250 100 0.5 3–10 14
CRAO Rose bengal,
20 mg/kg
Argon green
laser
532 100 75 0.4 NA 30
CRAO Rose bengal,
0.1 mL
Diode laser 532 490 300 0.300 NA 35
RAO (all
arteries)
Rose bengal,
50mg/kg
NA 532 650 75 0.5 NA 37
BRAO Rose bengal,
100 lL 1%
Diode laser 532 NA 75 NA NA 15
CRAO Rose bengal,
20 mg/kg
NA 514 100 or 150 200 NA NA 31
CRAO Rose bengal,
0.05 mL of
2.5 mM
YAG laser 514 100 or 150 200 0.1 20 29
CRAO Rose bengal,
20 mg/kg
NA 532 150 200 NA NA 36
BRAO - Red laser light NA 300 NA 0.3 NA 16
BRAO Rose bengal,
40 mg/kg
Slit-lamp
Krypton laser
NA 50 50 3.0 2-3 17
CRVO, central retinal vein occlusion; NA, not available/not applicable.
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study.85 Combined with epinephrine, this consistently
produced RAO and choriocapillaris occlusion.
Endovascular Technique
Three studies using endovascular techniques were
identified. All three studies were conducted by Morén
et al.86,87,88 and used pigs as experimental animals.
The arteries were catheterized using a transfemoral,
endovascular approach.
In one study, transient and permanent vascular
occlusions were performed using an angioplasty
balloon catheter in the ophthalmic artery or a liquid
embolic agent that was administered via an injection-
catheter.86 The liquid embolic agent could produce
occlusion of either the ophthalmic artery or the main
ciliary artery from which the retinal arteries branches.
Occlusion of the main ciliary artery produced
complete ischemia, in contrast to the ophthalmic
artery, which only produced incomplete ischemia.
In the other two studies, vascular occlusion was
produced by using coils in the ophthalmic artery.87,88
Evaluation of Successful Occlusion
In total, 41 of 88 included studies validated their
occlusion by the use of fundus examination, while 29
studies used ERG as a measure of the function of the
retina. Thirty-three studies used angiography (either
fluorescein angiography or indocyanine green angi-
ography), and 33 studies used histopathology to
evaluate differences in the architecture of the retina.
Twelve studies did not use any of these meth-
ods.16,17,27,29,44–46,61,63–65 A few studies used other
methods to validate or evaluate the occlusion, such as
visual-evoked potential or observing whitening of the
iris and the loss of the red reflex. Optical coherence
tomography was not performed in any of the studies.
Duration of the Occlusion
When using a setup with ligation, clamp, or
increased IOP, the duration of the occlusion was
controllable. The applied durations are listed in Table
3. Typically, the occlusion lasted 30 to 90 minutes
followed by a varied period of reperfusion.
Endovascular approach was permanent, except
when using balloon catheter, in which case the artery
was occluded for 1 hour.86
When inducing an occlusion by laser, the duration
of the occlusion has a methodologic limit as
spontaneous reperfusion occurs at a point, either
due to recanalization or development of collateral
circulation. Ten of 23 studies using laser reported the
duration of the occlusions (see Table 4). Large
differences existed between studies with the duration
varying from 3 hours to 2 weeks before reperfusion.
In many cases, there were no data on the exact time of
reperfusion, but intervals, minimums, or maximums
were given for the duration of the occlusion. One
study induced reperfusion by infusion of recombinant
tissue plasminogen activator.10
Studies using an occluder or probe maintained the
occlusion for periods ranging from 10 minutes to 4
hours.24–27
Constriction caused by endothelin-1 infusion was
in one study reported to last for approximately 5
minutes after which the effect declines,16 other studies
found it to last for at least 50 minutes.39,40 Injection in
the subconjunctival space caused constriction for 30
minutes.41
One study using embolization by injecting leuko-
cyte aggregates and subsequently exposing the ani-
mals to hypoxia reported the occlusions to last up to 8
days.20 Studies using other agents reported occlusions
lasting up to 166 seconds or 20 minutes.19,23
Discussion
Experimental animal models offer a unique op-
portunity to investigate different aspects of RAO.
However, caution is needed when findings are
extrapolated to the disease in humans. In order to
increase the usefulness and applicability of RAO
experiments, it is of utmost importance to imitate the
human disease as closely as possible. Ideally, the
anatomy of the animal should resemble that of the
human eye, the intervention should mimic the
occlusion of the retinal artery meaning the occlusion
of the retinal artery only, and avoid damage on other
tissues or structures.
Imitating the disease requires thorough knowledge
on the natural history of RAO. In this aspect, the
duration and extent of the occlusion is of interest. In a
fluorescein angiography study in which patients were
seen 4.4 days in average after the onset of symptoms,
only one in 62 patients with CRAO showed complete
absence of dye in the retinal arteries.98 However, the
arteriovenous transit time was found to be prolonged
in most cases. Hence, while there seems to be
consensus that in the clinical setting some residual
circulation remains, the mechanism is still debated. It
has been suggested to be due to an incomplete
obstruction by the embolus in the vessel.30,99,100 A
study by Hayreh and Jonas54 on clamping of the CRA
in monkeys reported of fluorescein angiographies
similar to that in humans showing residual circulation
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after CRAO. It was argued that it was due to
anastomoses with the CRA distal to the occlusion
allowing filling, that being cilioretinal capillary
anastomoses and pial and intraneural anastomoses.54
This mechanism is only possible if the site of
occlusion is proximal to the site of these anastomoses
(i.e., the dural sheath). Experimental methods using
increased IOP, ligation of multiple vessels, and
vasoconstriction causes complete obstruction of the
vessel(s) leaving no residual circulation, in contrast to
the clinical picture in man.
Due to time delay, the clinical findings at the very
onset of the occlusion is largely unknown. Although it
is uncertain when it begins, reperfusion ultimately
occurs in the majority of clinical cases. Hence, one
study found reperfusion to appear in all cases of
Table 3. Duration of Occlusions and Reperfusion for Studies Using Ligation, Clamping, or High IOP
Ligation Clamp
Occlusion,
Duration
Reperfusion,
Duration Reference
Occlusion,
Duration
Reperfusion,
Duration Reference
NA None 79 15–20, 45, 90 min,
2.25, 4.5 hr
Few hr–3 min 18
30, 60, 120 min,
4, 24 hr
None 80 15–280 min Up to 22 wk 55
30 min 180 min 83 NA NA 60
30–90 min 30 min–24 hr 82 At least 116 min NA 58
90 min 4 or 24 hr 76 At least 97 min Mean 64.5 mo 59
30 min 180 min 66 97–300 min NA 54
30 min 120 min 67 97–240 min 2–16 wk 5
60 min Up to 3 d 72 3 hr 6h 56
30 min NA 68 97–240 min 112 6 111 d 57
30 min NA 69
1, 5, 10, 20, 30,
60, 120 min
NA 81
90 min 1, 3, 5 min, 24 hr 77
30 min 240 min 70
30 min 240 min 71
60 min 6, 24, 72 hr 64
60 min 7 d 73
NA NA 38
90 min 120 min 61
NA NA 65
60 min 5 d 74
90 min 24 hr 78
30 or 90 min 3 or 12 hr 62
60 min 10 d 75
30 min 14 d 63
Table 3. Extended
High IOP
Occlusion,
Duration
Reperfusion,
Duration Reference
180 or 240 min 2, 4, or 6 wk 43
45 min 3–48 hr 88
Up to 60 min 7 d 87
45 min 7 d 63
45 m 6 hr–7 d 29
5 or 10 min 24 hr 85
50 min 0, 60 min, 6 or 24 hr 44
60 min 1, 3, 5, 7, 14 d 61
90 min 1 d 62
60 min NA 45
60 min 0, 60 min, 6, 24 hr, 7 d 84
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RAO, although in only 16 of the 29 patients with
visible emboli perfusion recovered within the first
month.97 A study on CRAO found only 15% of eyes
to have transient CRAO (lasting several minutes to
many hours), while 71% had permanent CRAO, and
14% had CRAO with cilioretinal artery sparing.101 In
the vast majority of the experimental studies, the
occlusion lasted only minutes to hours followed by
either spontaneous or induced/intended reperfusion.
Only the endovascular method produced permanent
occlusion. Therefore, it could be argued there are
dissimilarities between the majority of the experimen-
tal setups and the longer lasting CRAO in humans.
It has previously been argued in a study using
laser-induced thrombus that animal models that
depend on well-controlled reperfusion may produce
pathogenic information that is less relevant to the
clinical situation.30 It is argued that there is improved
clinical relevance in a CRAO model with an
intraluminal thrombus that can resolve naturally
and spontaneously and with long-term ischemia. On
the other hand, such a setup is less standardized and
reproducible.
Reperfusion following ischemia is thought to cause
damage to the tissue.6 If reperfusion takes place after
irreversible damage on the retina has already hap-
pened due to the ischemia, it may be less relevant to
allow reperfusion to happen in an experimental
model. This is especially true for studies investigating
biochemical responses with the objective to search for
potential mechanism of treatment.
A disadvantage of several of the models is that
they affect vessels other than the retinal artery.
Endothelin-1 causes constriction of all retinal vessels,
including veins. One study investigated the choroidal
blood flow following the administration of endothe-
lin-1 in rabbits.40 They found the choroidal blood
flow to increase, maybe due to regulatory mecha-
nisms. As for the method of increased IOP, even a
moderate increase in IOP causes a reduction in blood
flow in the choroid.40,102,103 In the majority of studies
using ligature, the ciliary arteries were ligated as well.
Injection of material to cause embolization was done
in either the carotid or maxillary artery, which may
very well have caused ischemia in tissues other than
the retina. When using an occluder or probe only the
inner retina is made ischemic. The same applies for
clamp in monkeys, laser, and, to some extent,
endovascular approach.
Some methods could produce features unrelated to
RAO, too. Elevation of IOP may result in both
vascular occlusion–induced ischemia and mechanical
injury to the retina. Öz et al.47 reported that their
model of increased IOP, ‘‘. . .has no similarity or
analogy to isolated vascular occlusion such as clinical
central retinal artery occlusion or ophthalmic artery
occlusion.’’ Ligation often included ligation of the
optic nerve. This induces mechanical and ischemic
damage to the optic nerve and may also induce
occlusion of the ciliary arteries resulting in choroidal
ischemia. This may confound the cell degeneration
attributed to ischemic damage from occlusion of the
Table 4. Reported Duration of Artery Occlusion Induced by Laser Before Spontaneous Reperfusiona
Species Method Site of Occlusion
Reported Duration
of Artery Occlusion Reference
Rodents Light þ rose bengal BRAO .60 min 8
Rodents Laser þ rose bengal CRAO ~6 hr 31
Rodents Laser þ rose bengal CRAO 3hr to .24 hr 30
Rabbits Laser þ rose bengal RAO (all arteries) 8 hr–1 d 37
Rodents Laser þ rose bengal CRAO At least 24–48 hr 32
Rabbits Light þ rose bengal BRAO (and CRVO) ,3 d 7
Rodents White light þ rose bengal BRAO Up to 3 d 9
Rabbits Laser þ phthalocyanine Vein and artery branch
þ choroidal vessels
2–4 d 11
Rabbits Laser þ chloro-aluminum
sulfonated phthalocyanine
Medullary ray (artery, vein,
and choroidal vessels)
72 hr –1 wk 28
Rabbits and
rodents
Laser targeted delivery þ
encapsulated photosensitizing
agent
BRAO At least 2 wk 12
a For studies reporting information on the duration only.
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CRA. Furthermore, ligation and clamping are inva-
sive, requiring dissection of the orbit area. Using laser
may cause damage due to the use of photosensitizer
and/or the laser itself.6 Furthermore, it seems
unavoidable to damage the optic nerve and possibly
the central retinal vein if CRAO is produced by
applying laser to the optic nerve.
Of all species used in these studies, the anatomy of
the nonhuman primates resembles that of the human
eye most closely, followed by that of pigs. On the
contrary, the rabbit appears to be a poor choice in
experimental models of human retinal artery occlu-
sions.96,38 Besides from the anatomy and the resem-
blance with human eyes, other factors are to be
considered in regard to the different species. The size
of the animal and the eye is of importance. Smaller
animals may be easier to handle and require smaller
housing facilities. On the other hand, larger animals
with eyes with the size of human eyes, such as the pig,
are an advantage or necessity in surgical methods,
such as endovascular approach or ligation of only the
CRA. Other factors include availability of the species
and economy.
If other researchers are to replicate previous
animal studies and benefit from their experience, the
method should be reproduceable. Especially the
embolization method causes varied results and only
some of the experiments resulted in BRAO. In
addition, there is limited experience with some
methods as they were only reported in few studies
(studies on occluder/probe, endovascular technique,
embolization).
To ensure critical evaluation and transparency,
studies should validate their method, ideally by
fundus examination, angiography, and ERG. These
results should then be reported. Multiple of the
included studies did not use any of these common
methods, and many of those that did, did not
document their findings. This makes it difficult to
compare studies as the evaluation of successful
occlusion is so diverse.
Conclusion and Recommendations for
Future Research
Although a broad range of approaches can be used
to model RAO in animals, future research on RAO
should use a suitable animal model, which is
anatomically and physiologically similar to humans.
Therefore, monkeys followed by pigs are to be
preferred and conversely, the rabbit appears to be a
poor choice. In addition, an animal model of RAO
must have an occlusion pattern that resembles
occlusive mechanisms in the human eye. A number
of animal models of RAO induce general ocular
ischemia resembling ocular ischemic syndrome. Mod-
els that induce global ocular ischemia may not be well
suited for studying RAO. We recommend methods
that result in RAO without damages to adjacent
ocular structures. Also, the duration and extent of the
ischemic period should mimic that in RAO in
humans. Although none of the described methods
meet all of the criteria of a perfect model some
methods seem to be superior compared with others.
Though it is invasive, ligation or clamp may be a
suitable model in larger animals as there is a potential
to isolate and occlude the retinal artery only. Laser-
induced occlusion is another suitable approach being
noninvasive and involving the retinal artery only.
However, our review demonstrates that reperfusion of
the occlusion is likely to occur. IOP, vasoconstriction,
and embolization may be less suitable models as the
resulting ischemia is not specific or stable enough.
Regardless of the model, documentation and valida-
tion by fundus photography and angiography are
indispensable for a successful study.
As no existing model is ideal, the methods may
supplement each other and model various specific
aspects of the disease, and thereby each contribute to
the understanding of the disease. Hence, a surgical or
laser-induced occlusion allows the basic reaction of the
tissue to the occlusion to be studied, although the
formation of a thrombosis or embolus in humans may
not be mimicked completely. However, future studies
are needed to develop a model with an actual
thromboembolism useful in the development of treat-
ments targeting the thrombus or emboli itself, such as
thrombolytics and surgical removal of the embolus.
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Malmsjö M. Angiography and multifocal elec-
troretinography show that blood supply to the
pig retina may be both ipsilateral and contra-
lateral. Invest Ophthalmol Vis Sci. 2013;54:6112–
6117.
89. Mutlu F, Leopold IH. Structure of the retinal
vascular system of the dog, monkey, rat, mouse
and cow. Am J Ophthalmol. 1964;58:261–270.
90. Bloodworth JMJ, Gutgesell HPJ, Engerman
RL. Retinal vasculature of the pig. Light and
electron microscope studies. Exp Eye Res. 1965;
4:174–178.
91. De Schaepdrijver L, Simoens P, Pollet L,
Lauwers H, De Laey JJ. Morphologic and
clinical study of the retinal circulation in the
miniature pig. B: Fluorescein angiography of the
retina. Exp Eye Res. 1992;54:975–985.
92. Albrecht May C. Comparative anatomy of the
optic nerve head and inner retina in non-primate
animal models used for glaucoma research.
Open Ophthalmol J. 2008;2:94–101.
93. Ollivier FJ, Samuelson DA, Brooks DE, Lewis
PA, Kallberg ME, Komáromy AM. Compara-
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